Teva Pharmaceutical Industries will cut about 5,000 jobs, 10 percent of its workforce Continue reading
Those jobs will be created over the next five years following a €380 million investment in its Irish operations. The investment, which is being supported by IDA Ireland, will include an expansion of Mylan’s research and development (R&D) capabilities here. Mylan is the largest so-called “generics” pharmaceutical manufacturer in Ireland, producing medicines that are no … Continue reading